Oliver Goodyear

1.9k total citations
21 papers, 1.3k citations indexed

About

Oliver Goodyear is a scholar working on Immunology, Hematology and Molecular Biology. According to data from OpenAlex, Oliver Goodyear has authored 21 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 9 papers in Hematology and 6 papers in Molecular Biology. Recurrent topics in Oliver Goodyear's work include Immune Cell Function and Interaction (8 papers), Immunotherapy and Immune Responses (7 papers) and Reproductive System and Pregnancy (4 papers). Oliver Goodyear is often cited by papers focused on Immune Cell Function and Interaction (8 papers), Immunotherapy and Immune Responses (7 papers) and Reproductive System and Pregnancy (4 papers). Oliver Goodyear collaborates with scholars based in United Kingdom, India and Germany. Oliver Goodyear's co-authors include Paul Moss, Guy Pratt, Charles Craddock, Shamyla Siddique, Paresh Vyas, Gordon B. Ryan, Karen Piper Hanley, D. Lissauer, Mark D. Kilby and Tatjana Stanković and has published in prestigious journals such as Blood, The Journal of Immunology and Journal of Virology.

In The Last Decade

Oliver Goodyear

20 papers receiving 1.3k citations

Peers

Countries citing papers authored by Oliver Goodyear

Since Specialization

Citations

This map shows the geographic impact of Oliver Goodyear's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Goodyear with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Goodyear more than expected).

Fields of papers citing papers by Oliver Goodyear

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Goodyear. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Goodyear. The network helps show where Oliver Goodyear may publish in the future.

Co-authorship network of co-authors of Oliver Goodyear

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Goodyear. A scholar is included among the top collaborators of Oliver Goodyear based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Goodyear. Oliver Goodyear is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Membrane adsorber design for lentiviral vector recovery 2025 ·Molecular Therapy — Methods & Clinical Development ·(unknown), (unknown), (unknown), Maria Kapanidou, (unknown), (unknown), (unknown), Oliver Goodyear, (unknown), Kyriacos Mitrophanous, (unknown), Florian Taft, Volkmar Thom, Daniel G. Bracewell, Lee Davies	2
2	Improved production and quality of lentiviral vectors by major-splice-donor mutation and co-expression of a novel U1 snRNA-based enhancer 2025 ·Heliyon ·J. Fraser Wright, Bruce Alberts, (unknown), Cristina Nogueira, Zsofia Miskolczi, Cleide Rosana Werneck Vieira, (unknown), (unknown), Oliver Goodyear, (unknown), (unknown), Daniel G. Blount, (unknown), Thibaud Coradin, Hsuan‐Cheng Huang, Magdalena Martín-Urdiroz, Sara Ferluga, Kyriacos Mitrophanous, (unknown), (unknown)	0
3	Neoplastic plasma cells generate an inflammatory environment within bone marrow and markedly alter the distribution of T cells between lymphoid compartments 2017 ·Oncotarget ·Oliver Goodyear, Sarah Essex, (unknown), Supratik Basu, Paul Moss, Guy Pratt	5
4	Tolerability and Clinical Activity of Post-Transplantation Azacitidine in Patients Allografted for Acute Myeloid Leukemia Treated on the RICAZA Trial 2015 ·Biology of Blood and Marrow Transplantation ·Charles Craddock, (unknown), Shamyla Siddique, Christina Yap, (unknown), Sandeep Nagra, Janice Ward, Paul Ferguson, (unknown), Richard J. Buka, Paresh Vyas, Oliver Goodyear, Eleni Tholouli, Charles Crawley, Nigel H. Russell, Jenny Byrne, Ram Malladi, John A. Snowden, Mike Dennis	128
5	Targeting ß2 adrenergic receptors regulate human T cell function directly and indirectly 2014 ·Brain Behavior and Immunity ·(unknown), Jos A. Bosch, Oliver Goodyear, Natalie E. Riddell, Helen M. McGettrick, Paul Moss, Graham R. Wallace	30
6	Profile of maternal CD4 T-cell effector function during normal pregnancy and in women with a history of recurrent miscarriage 2013 ·Clinical Science ·D. Lissauer, Oliver Goodyear, (unknown), Paul Moss, Mark D. Kilby	37
7	Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML) 2012 ·Blood ·Oliver Goodyear, Mike Dennis, (unknown), Justin Loke, Shamyla Siddique, Gordon B. Ryan, Jane Nunnick, (unknown), Manoj Raghavan, Mark Cook, John A. Snowden, Mike Griffiths, Nigel H. Russell, John Yin, Charles Crawley, Gordon Cook, Paresh Vyas, Paul Moss, Ram Malladi, Charles Craddock	301
8	Suppression of Antigen-Specific T Cell Responses by the Kaposi's Sarcoma-Associated Herpesvirus Viral OX2 Protein and Its Cellular Orthologue, CD200 2012 ·Journal of Virology ·(unknown), Simon A. Chanas, Seyed Abdolrahim Rezaee, (unknown), Laura L. Quinn, Heather M. Long, Oliver Goodyear, Janet M. Lord, Andrew D. Hislop, David J. Blackbourn	36
9	Fetal-Specific CD8+ Cytotoxic T Cell Responses Develop during Normal Human Pregnancy and Exhibit Broad Functional Capacity 2012 ·The Journal of Immunology ·D. Lissauer, Karen Piper Hanley, Oliver Goodyear, Mark D. Kilby, Paul Moss	109
10	Dominant responses with conservation of T-cell receptor usage in the CD8+ T-cell recognition of a cancer testis antigen peptide presented through HLA-Cw7 in patients with multiple myeloma 2011 ·Cancer Immunology Immunotherapy ·Oliver Goodyear, Hayden Pearce, Guy Pratt, Paul Moss	6
11	Cytomegalovirus sero-positivity dramatically alters the maternal CD8+ T cell repertoire and leads to the accumulation of highly differentiated memory cells during human pregnancy 2011 ·Archives of Disease in Childhood Fetal & Neonatal ·D. Lissauer, (unknown), (unknown), Oliver Goodyear, Paul Moss, Mark D. Kilby	9
12	Cytomegalovirus sero positivity dramatically alters the maternal CD8+ T cell repertoire and leads to the accumulation of highly differentiated memory cells during human pregnancy 2011 ·Human Reproduction ·D. Lissauer, (unknown), Annette Pachnio, Oliver Goodyear, Paul Moss, Mark D. Kilby	23
13	Azacitidine Induces Expansion of Regulatory T Cells and Tumour Specific CD8+ T Lymphocytes After Allogeneic Stem Cell Transplantation: A Strategy for Epigenetic Manipulation of a Graft-Versus-Leukemia Response 2011 ·Blood ·Mike Dennis, Oliver Goodyear, Justin Loke, (unknown), Shamyla Siddique, Gordon B. Ryan, (unknown), John A. Snowden, Mike Griffiths, Nigel H. Russell, John Yin, Charles Crawley, Gordon Cook, Paresh Vyas, Paul Moss, Ram Malladi, Charles Craddock	1
14	CD8+ T-cell immunity against cancer-testis antigens develops following allogeneic stem cell transplantation and reveals a potential mechanism for the graft-versus-leukemia effect 2010 ·Haematologica ·Andrew McLarnon, Karen Piper Hanley, Oliver Goodyear, Julie Arrazi, P Mahendra, Mark Cook, Fiona Clark, Guy Pratt, Charles Craddock, Paul Moss	14
15	Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasia 2010 ·Blood ·Oliver Goodyear, Angelo Agathanggelou, Igor Novitzky‐Basso, Shamyla Siddique, Tina McSkeane, Gordon B. Ryan, Paresh Vyas, Jamie Cavenagh, Tatjana Stanković, Paul Moss, Charles Craddock	265
16	The Epigenetic Therapies Azacitidine and Sodium Valproate Augment Immune Responses to the MAGE Cancer Testis Antigen in Acute Myeloid Leukemia and Myeloma. 2009 ·Blood ·Oliver Goodyear, Angelo Agathanggelou, Gordon B. Ryan, (unknown), Tatjana Stanković, Paul Moss, Charles Craddock	1
17	Differential pattern of CD4+ and CD8+ T-cell immunity to MAGE-A1/A2/A3 in patients with monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma 2008 ·Blood ·Oliver Goodyear, Guy Pratt, Andrew McLarnon, Mark Cook, Karen Piper Hanley, Paul Moss	32
18	Epigenetic Manipulation of Cancer Testis Antigen (CTA) Expression: A Strategy for Manipulating the Graft-Versus Leukaemia Response in Patients Allografted for Haematological Malignancies 2008 ·Blood ·Tatjana Stanković, Andrew McLarnon, Angelo Agathanggelou, Oliver Goodyear, Charles Craddock, Paul Moss	5
19	Immunodeficiency and immunotherapy in multiple myeloma 2007 ·British Journal of Haematology ·Guy Pratt, Oliver Goodyear, Paul Moss	255
20	CD8+T cells specific for cancer germline gene antigens are found in many patients with multiple myeloma, and their frequency correlates with disease burden 2005 ·Blood ·Oliver Goodyear, Karen Piper Hanley, Naeem Khan, Jane Starczynski, Prem Mahendra, Guy Pratt, Paul Moss	64

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact